Showing results (1431-1440 of 1,903) with videos related to
Sort By:
Pageof 191
International Journal of Cancer|November 26, 2003
Analysis of gene expression profiles in human HL-60 cell exposed to cantharidin using cDNA microarrayJun-Ping Zhang, Kang Ying, Zhen-Yu Xiao, et al.Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment|January 17, 2019
Concentration of morpholine residues in major fruits and juices and its dietary exposure in ChinaPei Cao, Da-Wei Chen, Jiang Liang, et al.Obstetrics and Gynecology|April 12, 2003
Therapeutic equivalence of alendronate 35 milligrams once weekly and 5 milligrams daily in the prevention of postmenopausal osteoporosisMarjorie M Luckey, Nigel Gilchrist, Henry G Bone, et al.Journal of Cellular and Molecular Medicine|July 20, 2018
MircoRNA-1275 promotes proliferation, invasion and migration of glioma cells via SERPINE1Dong-Mei Wu, Shan Wang, Xin Wen, et al.BMC Plant Biology|August 15, 2018
Transcriptome and DNA methylome reveal insights into yield heterosis in the curds of broccoli (Brassica oleracea L var. italic)Hui Li, Jiye Yuan, Mei Wu, et al.Molecules (Basel, Switzerland)|July 4, 2018
New Bisabosquals from Stachybotrys sp. PH30583 Elicited on Solid MediaBao-Hui Ruan, Shu-Quan Li, Xue-Qiong Yang, et al.World Journal of Gastroenterology|August 19, 2007
Construction of targeted plasmid vector pcDNA3.1-Egr.1p-p16 and its expression in pancreatic cancer JF305 cells induced by radiation in vitroHong-Bing Ma, Xi-Jing Wang, Zheng-Li Di, et al.Journal of Cellular Biochemistry|September 13, 2014
CERS2 suppresses tumor cell invasion and is associated with decreased V-ATPase and MMP-2/MMP-9 activities in breast cancerShao-hua Fan, Yan-yan Wang, Jun Lu, et al.Haematologica|December 17, 2020
The impact of early discontinuation/dose modification of venetoclax on outcomes in patients with relapsed/refractory chronic lymphocytic leukemia: post-hoc analyses from the phase III MURANO studyAnthony R Mato, Jeff P Sharman, Juliana M L Biondo, et al.Oncotargets and Therapy|February 28, 2022
Rapid and Efficient Response to Gilteritinib and Venetoclax-Based Therapy in Two AML Patients with FLT3-ITD Mutation Unresponsive to Venetoclax Plus AzacitidineLei-Si Zhang, Jun Wang, Ming-Zhu Xu, et al.Pageof 191